More Globe Newswire

View Older Stories View Newer Stories

May 23, 2024 09:49PM Imperial Announces Voting Results for the Election of Directors
May 23, 2024 09:37PM Introducing Optimum AI: Revolutionizing DeFi with Text-Based Trading on WhatsApp and Telegram
May 23, 2024 09:03PM Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
May 23, 2024 09:00PM DIRECT DIGITAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Direct Digital Holdings, Inc. and Encourages Investors to Contact the Firm
May 23, 2024 08:00PM HUTCHMED Highlights Presentations at the 2024 ASCO Annual Meeting
May 23, 2024 07:30PM Tornado Global Hydrovacs Reports First Quarter 2024 Results
May 23, 2024 07:21PM Jamieson Wellness Inc. Announces Voting Results from 2024 Annual Meeting of Shareholders
May 23, 2024 07:00PM LexinFintech Holdings Ltd. Reports First Quarter 2024 Unaudited Financial Results
May 23, 2024 06:38PM Restaurants Canada Expresses Concern as BC Restaurants Brace for Chicken Price Surge
May 23, 2024 06:37PM AXTI Stockholders: Robbins LLP Reminds AXTI Stockholders of Securities Fraud Class Action Against AXT, Inc.
May 23, 2024 06:27PM Mediacom Communications Ready to Connect Customers in First Phase of 221-Mile Seminole County Fiber Network Buildout
May 23, 2024 06:04PM Western Pacific Trust Company Announces Q1-2024 Results
May 23, 2024 06:01PM The Dominican Republic and Purdue University Sign MOU to Drive Semiconductor Growth
May 23, 2024 06:00PM Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting
May 23, 2024 06:00PM Associa Recognized as a US Best Managed Company
May 23, 2024 06:00PM Huize Holding Limited Reports First Quarter 2024 Unaudited Financial Results
May 23, 2024 05:55PM Gildan Board of Directors Resigns
May 23, 2024 05:52PM Acceleware Ltd. Reports First Quarter 2024 Financial and Operating Results
May 23, 2024 05:51PM Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti
May 23, 2024 05:49PM Parks! America, Inc. Announces Glass Lewis Recommends Parks! America Shareholders Vote “FOR” Each of the Director Nominees Recommended by the Board
May 23, 2024 05:49PM CORRECTION – The Herzfeld Caribbean Basin Fund, Inc. Announces Distribution in Stock and Cash
May 23, 2024 05:41PM Mountain America Credit Union Named Utah's Leading SBA Lender for Third Consecutive Year
May 23, 2024 05:40PM Stockholder Alert: Robbins LLP Informs Investors that a Class Action has been filed Against Cambium Networks Corporation (CMBM)
May 23, 2024 05:33PM 3Daughters to Participate in Women’s Health Panel During the 2024 BIO International Convention in San Diego, CA, June 3-6
May 23, 2024 05:30PM Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
May 23, 2024 05:30PM Premier Health Reports 2024 Second Quarter Results
May 23, 2024 05:30PM Titanium Transportation Group Declares Quarterly Dividend
May 23, 2024 05:29PM ALT Stockholders: Robbins LLP Reminds ALT Stockholders of Securities Fraud Class Action Against Altimmune, Inc.
May 23, 2024 05:25PM MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoStar Group
May 23, 2024 05:25PM MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoStar Group
May 23, 2024 05:22PM HRBR Stockholders: Robbins LLP Reminds HRBR Stockholders of Securities Fraud Class Action Against Harbor Diversified, Inc.
May 23, 2024 05:23PM DOCS INVESTOR NEWS: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS
May 23, 2024 05:22PM Trailblazing Dragons' Den Star Named United Nations Association in Canada's 2024 Global Citizen Laureate
May 23, 2024 05:21PM INTC Stockholders: Robbins LLP Reminds INTC Stockholders of Securities Fraud Class Action Against Intel Corporation
May 23, 2024 05:18PM Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
May 23, 2024 05:18PM Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
May 23, 2024 05:15PM Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:13PM SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:11PM Special Olympics Florida and Orlando Health Announce Five-Year Partnership
May 23, 2024 05:10PM Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101
May 23, 2024 05:09PM Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
May 23, 2024 05:06PM G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
May 23, 2024 05:05PM Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting
May 23, 2024 05:05PM FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (m
May 23, 2024 05:05PM NKGen Biotech Publishes Phase 1 Interim Analysis Results of SNK02 Allogeneic NK Cell Therapy in Advanced Solid Tumors at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:05PM Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
May 23, 2024 05:05PM BioAtla Presenting Phase 1 Evalstotug Clinical Trial Data Demonstrating Clinical Benefit at the Upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
May 23, 2024 05:05PM Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the
May 23, 2024 05:05PM I-Mab Announces Encouraging Phase 1 Clinical Data of PD-L1x4-1BB Bispecific Antibody Ragistomig at ASCO 2024
May 23, 2024 05:05PM Elcora Announces Share Consolidation
View Newer Stories View Older Stories